The visit of Secretary of State Michelle Donelan to mark the future site of UK Biobank’s new £75 million centre at Bruntwood SciTech’s Manchester Science Park represents a significant milestone for the organization and for biomedical research.
UK Biobank is renowned as the world’s most comprehensive repository of health data, providing invaluable insights to approved researchers worldwide.
The forthcoming state-of-the-art facility, spanning 131,000 square feet and occupying three floors, will serve as a hub for cutting-edge research in the biomedical sciences.
Key features of the new building include laboratory space and a next-generation robotic freezer capable of storing and retrieving UK Biobank’s 20 million biological samples at unprecedented speed, thereby accelerating scientific discovery.
Supported by a substantial £127.6 million award from the UK Research and Innovation (UKRI) Infrastructure Fund, this development marks the next phase of UK Biobank’s evolution.
Situated alongside thriving life science businesses specializing in diagnostics, genomics, biotech, and precision medicine, the purpose-built facility will facilitate collaboration and innovation.
With specialized features such as enhanced cooling and ventilation systems, high security access, and 100GB superfast connectivity, the new center is poised to drive advancements in research and development.
The commitment to sustainability is evident, with plans for the facility to be 100% electric and achieve net zero carbon emissions in both construction and operation. This aligns with UK Biobank’s mission to advance research while minimizing its environmental impact.
The new centre represents a significant investment in the future of UK Biobank, empowering researchers to make groundbreaking discoveries in disease prevention and treatment.
As a pivotal resource in the biomedical sciences, UK Biobank continues to drive innovation, create employment opportunities, and enhance public health outcomes.